Posts in tag

osteoarthritis


Supported by GSK Consumer Healthcare All modified release paracetamol products have now changed from Pharmacy Medicine (Schedule 2) to Pharmacist Only Medicine (Schedule 3). Former PSA president, John Bell discusses …

Supported by GSK Consumer Healthcare All modified release paracetamol products changed from Pharmacy Medicine (Schedule 2) to Pharmacist Only Medicine (Schedule 3). Former PSA president, John Bell discusses how this …

Debbie Rigby takes a look at the latest in research news  Risk Versus Benefit of Combined Aspirin and Warfarin Therapy in Patients With Atrial Fibrillation In this retrospective, cohort study …

Supported by GSK Consumer Healthcare All modified release paracetamol products have now changed from Schedule 2 to Schedule 3 medicine. Former PSA president, John Bell discusses what this means for pharmacists …

Debbie Rigby rounds up the latest in research news Amiodarone in the aged Amiodarone is a highly effective antiarrhythmic drug, but can have serious adverse effects, particularly in older patients. …

Debbie Rigby takes a look at the latest in research news Safety of Proton Pump Inhibitors in patients receiving rivaroxaban or aspirin In a large placebo-controlled randomized trial, pantoprazole was …

Debbie Rigby takes a look at the latest in research news Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy In this population-based …

Dr Esther Lau and Professor Lisa Nissen explore the daily difficulties faced by people living with arthritis Imagine waking up every day feeling like you have been hit by a …

Changes in the weather are not connected with back pain or osteoarthritis symptoms, Australian researchers have concluded A study comparing weather patterns with pain symptoms has shown no association between …

AJP asked readers if this ‘go-to’ drug is effective for acute and chronic pain conditions Recently the Director of Pain Research at the University of Oxford, Professor Andrew Moore, argued …

Effective and safe? This leader in pain research asks pharmacists to think again about this widely used drug While paracetamol has been the ‘go-to’ medicine for acute and chronic pain …